Tel: +49 (0) 89 517 286 59 0
E-Mail: info@pelobiotech.com

Stay up-to-date and never miss a thing.

Exciting news from PELOBiotech and Partners.

Nature Skin cells.png

PELOPaper: Advanced Skin Research with a Psoriasis Skin Equivalent Model

From chb/ovi 09. Januar 2025 3 min

A recent study introduces a bilayered skin equivalent that closely mimics psoriasis. This innovative model bridges a critical gap in preclinical studies, offering unparalleled insights into disease mechanisms and potential therapeutic interventions.

Read more...
Kevin LSEC paper(2).png

PELOPaper: Insights into Liver Endothelial Cell Function in Cirrhosis with PELOBiotech Products

From chb 16. Dezember 2024 2

A study published in Cellular and Molecular Gastroenterology and Hepatology highlights advances in understanding liver sinusoidal endothelial cells ...

Read more...
BBB(1).png

PELOPaper: Blood-Brain Barrier Disruption in Autoimmune Encephalitis

From Ovi 05. Dezember 2024 2

A recent dissertation from Charité – Universitätsmedizin Berlin by Lucie Yuanting Li explores the role of autoantibodies in autoimmune ...

Read more...
Lung_fibroblast_v1.png

PELOPaper: Cellovations® Lung Fibroblasts to Create 3D Vasculature-on-Chip Models

From chb 25. November 2024 2 min

A recent study published in Advanced Materials Technologies highlights Cellovations® products in advancing tissue engineering and microfluidic ...

Read more...
Gruppenfoto.jpg

2024 Trade Show Season Concludes with Success at MuSkITYR Symposium

From Ovi 11. November 2024 1 min

We are pleased to announce the successful conclusion of our 2024 trade show engagements, culminating at the MuSkITYR Symposium in Vienna. Our CEO and CSO, Dr. Lothar Steeb, had an engaging and productive experience, and we look forward to connecting with everyone again next year.

Read more...
nymz9syjfr2hg0s36oq6.png

iPSC-Derived Cardiomyocytes: Advancing Cardiac Research & Drug Discovery

From KAb 12. Oktober 2024 5 min
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are transforming cardiac research and drug discovery. Pioneered by Takahashi and Yamanaka, these cells are crucial for disease modeling and drug safety. Companies like NEXEL lead with innovations like the Cardiosight®-S platform. Despite challenges, advancements in hiPSC-CM maturity and organ-on-a-chip integration promise breakthroughs in personalized medicine.
Read more...
national-cancer-institute-p1zy6izFI0M-unsplash.jpg

Extracellular Vesicles (EVs) Explained: The Ultimate Guide to Exosome Research in 2024

From KAb 01. Oktober 2024 10 min
Unlock the secrets of extracellular vesicles (EVs) and explore their groundbreaking role in cell communication, disease pathways, and targeted therapies. From cancer to heart disease, exosomes and microvesicles are revolutionizing personalized medicine and drug delivery, paving the way for innovative diagnostic and treatment strategies.
Read more...
GSEV_Julian.png

Meet us at... GSEV 2024

From Ovi 20. September 2024 1 min

Moving in the conference season... Meet us at... GSEV: German Society for Extracellular Vesicles, October 1-2, 2024 in Hamburg, Germany

Read more...
E-Mail schreiben Jetzt anrufen